Experts warn that there is the risk of spreading infectious diseases incurable in unimaginable scale, writes The Independent. The reason — the increasing number of "superbugs" that are not affected by any antibiotics, and loss of interest in developing new drugs, says journalist Jeremy Laurance.
From Europe have been increasing reports of patients virtually untreatable infections. According to the European Centre for Disease Prevention and Disease Control (ECDC), in some countries up to 50% of cases of blood poisoning caused by bacteria K.pneumoniae, can not cure the carbapenems — the most powerful antibiotics. Meanwhile K.pneumoniae — Klebsiella pneumoniae — not some exotic bacteria, and common causes inflammation of the respiratory and urinary system, which is present in the intestines and is spread by touching dirty objects. In Europe, the incidence of infection of this kind of bacteria resistant to carbapenems, has grown from 7 to 15%. "This is particularly disturbing, since this class of antibiotics — the last resort for treatment of infections resistant to other drugs," — the author notes. Cases reported in Greece, Italy, Austria, Hungary and Cyprus.
"In 2010, as it became more strains of E. coli are resistant to antibiotics," — the author writes. In Italy and Spain, 25-50% of cases of infection with Escherichia coli could not heal fluorokinolonom.
"In the UK found 70 carriers of the bacteria, which contains the so-called NDM-1 — an enzyme that destroys carbapenems. Another study found that more than 80% of travelers who return from India to Europe, bring in their intestines gene NDM", — says the article .
Scientists warn that if the gene that triggers the synthesis of NDM-1 will spread wider, horrific events will turn.
In October, the UK Department of Health warned doctors that now gonorrhea should be treated with the two drugs simultaneously, and from some common drugs should be abandoned, as it has lost effectiveness. "The threat of untreatable gonorrhea in the future is real," — said the representative office.
As for the development of new drugs "superbugs", this work is expensive and difficult. "These drugs are taking courses of short duration, so the commercial income is low," — says the publication. The European Commission yesterday announced a program that will encourage research into new antibiotics — promised an expedited certification of new products and development funding in the form of public-private partnership.
According to statistics, in the EU each year about 25 thousand people die from infections resistant to antibiotics. Most of these infections occur in Greece, Italy, Hungary, Bulgaria and Cyprus. "As a rule, the same country — on the top lines on the use of antibiotics," — emphasizes the newspaper.
Two years ago, the WHO warned that the risk of abuse of antibiotics to bring peace back to the past, when the infection has been cured. "Warning is not heeded," — the newspaper said.
For its part, the British Ministry of Health does not recommend long courses of antibiotics and antibiotic preference focused treatment — against specific infections.